Getinge AB (OTCPK:GNGBF)
$ 17.85 0 (0%) Market Cap: 4.95 Bil Enterprise Value: 5.58 Bil PE Ratio: 29.80 PB Ratio: 1.49 GF Score: 86/100

Q1 2021 Getinge AB Earnings Call Transcript

Apr 20, 2021 / 08:00AM GMT
Release Date Price: $28.55
Operator

Hello, and welcome to the Getinge AB Q1 Report 2021. (Operator Instructions) Just to remind you, this conference call is being recorded.

Today, I'm pleased to present Mattias Perjos, CEO. Please begin with your meeting.

Mattias Perjos
Getinge AB - CEO, President & Director

Thank you very much, and welcome to today's conference, everyone. I have Lars Sandström, our CFO, with me, and he will present the financials a little bit later on.

But let's move directly over to Page #2, please. So we'll start with a bit of a summary from a financial perspective of the first quarter. So these are the key takeaways. We had organic net sales growth of 12.6% for the first quarter of this year. This is mainly explained by large deliveries of products for Sterile Transfer and ECMO therapy, where we expect continued strong demand going forward as well. We also delivered a large number of advanced ICU ventilators in the quarters, but expect sales events to return to more normal levels for the full year of 2021. So we confirm what we've said earlier in that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot